Study of Rilonacept for cardiac sarcoidosis
Part of Heart & circulation clinical trials.
This trial tests if rilonacept can help people with cardiac sarcoidosis, a condition where inflammation affects the heart. You may join if you have active inflammation on a PET scan despite standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cardiac sarcoidosis diagnosed by standard guidelines
- You have at least 3 areas of active inflammation on a PET scan within the last 8 weeks
- You are willing to wear a heart rhythm monitor at certain times
- You are between 18 and 80 years old
- You are not pregnant or breastfeeding and agree to use birth control if needed
- You do not have certain other medical conditions or use specific medications listed in the full criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a drug can help suppress sugar uptake in the heart for clearer imaging. It may help researchers understand how to better see heart problems.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This study tests whether a tracing agent called tilmanocept can help doctors see inflammation in the heart caused by sarcoidosis. It may provide a new way to diagnose and monitor cardiac sarcoidosis without invasive procedures.
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
This study collects and analyzes blood or tissue samples from people with cardiac sarcoidosis or inflammatory cardiomyopathy to better understand these conditions. The goal is to improve diagnosis and treatment, which may help manage heart failure and arrhythmias.
This study follows people with sarcoidosis that may or may not be affecting the heart. It uses special scans (PET and MRI) to look for heart involvement and track how the disease changes over time.
Hear when a new Cardiac Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.